Abstract

Pokeweed antiviral protein (PAP) from P. americana is a ribosome inactivating protein (RIP) and is an N‐glycosidase that removes specific purine residues from the sarcin/ricin (S/R) loop of the large rRNA, arresting protein synthesis at the translocation step. PAP is a potent antiviral agent against many plant, animal, and human viruses. PAP inhibits translation in cell extracts by binding to the cap structure of eukaryotic mRNA and viral RNA and depurinates them at multiple sites downstream of the cap structure (Hudak, K. A., et al. RNA (2002) 8: 1148–59). This mechanism does not clarify inhibitory effect of PAP on the replication of uncapped viruses, and thus the overall mechanism of PAP antiviral activity remains to be elucidated. In this work, fluorescence spectroscopy and HPLC techniques were used to quantitatively describe binding and enzymatic activities of PAP and its variants towards tobacco etch virus (TEV) RNAs, and thus understand the molecular basis behind PAP antiviral activity. The TEV RNA 5′‐leader is sufficient to confer cap‐independent translation, and contains an internal ribosome entry site (IRES) (Zeenko, V. and Gallie, D. R. J Biol Chem (2005) 280: 26813–24). We show that PAP possesses different binding and enzymatic domains within its structure, as well as that full 143‐nt TEV RNA leader sequence is required for PAP depurination of both m7GpppG‐capped and uncapped viral RNAs.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.